Global Genetic Toxicology Testing Market Projected to Grow at 10% CAGR, Reaching $2.64 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Genetic Toxicology Testing Industry Market Size Be by 2025?
The market size for genetic toxicology testing has expanded swiftly over the past few years. Its growth is projected to increase from $1.63 billion in 2024 to $1.8 billion in 2025, marking a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this historic growth include emerging public health emergencies, augmented globalization, growing attention towards personalized medicine, escalating demand for thorough testing solutions, and a rise in the number of drugs.

What's the Long-Term Growth Forecast for the Genetic Toxicology Testing Market Size Through 2029?
The market for genetic toxicology testing is forecasted to experience significant expansion in the coming years, with an estimated value of $2.64 billion in 2029 and a compound annual growth rate (CAGR) of 10.0%. This anticipated surge in the forecasted period is due to factors such as a growing demand for the testing of new food products, an increase in potential risk awareness, deepening health and environmental issues, elevated regulatory supervision, the proliferation of in vitro testing approaches, and the emergence of high-throughput screening platforms. Impending trends during this period include progressive breakthroughs in precision medicine and toxicogenomic, thorough risk communication, methodologies for genetic toxicology testing, triggering risk assessment methodology enhancements, merging of omics technologies, and advances in genomics and molecular biology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What Are the Key Growth Drivers Fueling the Genetic Toxicology Testing Market Expansion?
The growing need for customized health care, specifically personalized medicine, is predicted to fuel the expansion of the genetic toxicology testing market. Personalized medicine refers to a medical paradigm that customizes health care decisions, practices, interventions, and products based on the patient's anticipated response or disease susceptibility. The market for this personalized approach to healthcare has seen positive growth due to genetic discoveries, improved knowledge of diseases, the availability of diagnostic biomarkers, the implementation of value-based healthcare initiatives, and its incorporation into clinical practice and research. Genetic toxicology testing plays a crucial role in personalized medicine by offering vital data on genetic diversity, vulnerability to genotoxic substances, and treatment responses. For example, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that in 2023, the FDA sanctioned 16 new personalized medicines for patients with rare diseases, up from six in 2022. Thus, the increased demand for personalized medicine is propelling the genetic toxicology testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What Are the Key Trends Driving Genetic Toxicology Testing Market Growth?
Leading firms within the genetic toxicology testing market are concentrating their efforts on developing cutting-edge drug screening platforms such as phenotypic drug screening, with the aim of enhancing accuracy and efficiency in detecting potential genetic toxins. The technique of phenotypic drug screening is utilized in drug discovery and tests compounds based on their capacity to induce a specific cellular or physiological reaction within a whole organism or relevant cell system. For example, in August 2022, the American biotech company Creative Biogene unveiled disease models using zebrafish to aid in drug discovery and toxicological studies. These models are designed to imitate human genetic diseases in zebrafish, affording insights into disease mechanisms, drug discovery, and toxicology. The zebrafish models offered by Creative Biogene provide a significant platform for evaluating drug toxicity, predicting the safety of new compounds, and facilitating the drug development process.

How Is the Genetic Toxicology Testing Market Segmented?
The genetic toxicology testing market covered in this report is segmented -

1) By Type: In Vitro, In Vivo
2) By Product: Services, Reagents And Consumables, Assays
3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:
1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods
2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Which Companies Are Leading the Charge in Genetic Toxicology Testing Market Innovation?
Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Which Regions Are Leading the Global Genetic Toxicology Testing Market in Revenue?
North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.